Director/PDMR Shareholding

Allergy Therapeutics PLC
02 November 2006

1 November 2006



Allergy Therapeutics plc



Grant of Options



Allergy Therapeutics plc (the "Company") announces that on 9 October 2006,
provisional shares of 0.1 pence each in the share capital of the Company were
awarded to Keith Carter (Chief Executive Officer), Ian Postlethwaite (Finance
Director), Christian Gratz (Executive Director) and Tom Holdich (Executive
Director) at nil cost, pursuant to the Allergy Therapeutics plc 2005 Long Term
Share Incentive Plan (the "LTIP"), as follows:


Director                Number of           Date from which     Expiry date        Total provisional
                        provisional shares  exercisable                            shares held under
                        awarded                                                    LTIP
Keith Carter            142,500             9th October 2009    9th October 2016   342,500
Ian Postlethwaite       95,000              9th October 2009    9th October 2016   225,000
Christian Gratz         95,000              9th October 2009    9th October 2016   225,000
Tom Holdich             95,000              9th October 2009    9th October 2016   225,000



Distribution of ordinary shares of 0.1 pence each under the LTIP is conditional
on the Company's performance over the course of the next three financial years.










                      This information is provided by RNS
            The company news service from the London Stock Exchange